Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy

PHASE3CompletedINTERVENTIONAL

Enrollment

515

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

January 31, 2007

Conditions

Chronic Hepatitis C

Interventions

DRUG

Daily Infergen (Interferon Alfacon-1, CIFN) (9 or 15 µg) + Ribavirin (1000-1200 mg, based on body weight) PO Daily for up to 48 wks

All Listed Sponsors

lead

Bausch Health Americas, Inc.

INDUSTRY

NCT00086541 - Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy | Biotech Hunter | Biotech Hunter